Theranos lays off most of its remaining workforce: WSJ

(Reuters) – Embattled blood-testing company Theranos Inc laid off most of its remaining workforce to preserve cash and avert or at least delay bankruptcy for a few more months, the Wall Street Journal reported on Tuesday, citing people familiar with the matter.

The layoffs take the company’s head count from about 125 employees to two dozen or fewer, the Journal reported.

Theranos and its chief executive, Elizabeth Holmes, agreed to settle “massive fraud” charges with the U.S. Securities and Exchange Commission last month.

Under the SEC settlement, Holmes was forced to relinquish her voting control over the company she founded, return millions of shares to the privately held company and pay a $500,000 penalty.

Holmes also agreed to be barred from serving as an officer or director of a public company for 10 years.

The company did not immediately respond to a request for comment.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.